.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Baxter
QuintilesIMS
UBS
Covington
US Army
McKesson
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson

Generated: June 23, 2017

DrugPatentWatch Database Preview

YONDELIS Drug Profile

« Back to Dashboard

Which patents cover Yondelis, and what generic Yondelis alternatives are available?

Yondelis is a drug marketed by Janssen Prods and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-nine patent family members in thirty-five countries.

The generic ingredient in YONDELIS is trabectedin. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trabectedin profile page.

Summary for Tradename: YONDELIS

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list16
Clinical Trials: see list39
Patent Applications: see list10
Drug Prices:see details
DailyMed Link:YONDELIS at DailyMed

Pharmacology for Tradename: YONDELIS

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Prods
YONDELIS
trabectedin
POWDER;IV (INFUSION)207953-001Oct 23, 2015RXYesYes8,895,557► SubscribeY ► Subscribe
Janssen Prods
YONDELIS
trabectedin
POWDER;IV (INFUSION)207953-001Oct 23, 2015RXYesYes► Subscribe► Subscribe
Janssen Prods
YONDELIS
trabectedin
POWDER;IV (INFUSION)207953-001Oct 23, 2015RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: YONDELIS

Country Document Number Estimated Expiration
China102018714► Subscribe
Jordan2464► Subscribe
Honduras2005029978► Subscribe
BrazilPI0517238► Subscribe
South Korea20070091121► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Chinese Patent Office
Moodys
Farmers Insurance
Cantor Fitzgerald
McKesson
US Department of Justice
Novartis
Deloitte
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot